Overview

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Treatments:
Methadone